Side-by-side comparison
Retatrutide vs Cagrilintide — Price & Profile Comparison
Retatrutide
Triple-Action Metabolic CompoundGLP-1 / metabolic research
Cagrilintide
Metabolic Research PeptideGLP-1 / appetite research
The short answer
Retatrutide vs Cagrilintide: which to choose
Retatrutide is the cheaper option — roughly $24 vs $49 for the lowest verified listing. Retatrutide is the more widely stocked of the two (57 vendors vs 31). They target different goals — Retatrutide is a triple-action metabolic compound compound while Cagrilintide is a metabolic research peptide one — so they're often complementary rather than direct substitutes.
Research products are not for human use. Looking for clinician-supervised care instead? Retatrutide is investigational; compare currently available clinician-guided GLP-1 options.
Compare supervised options →Price Comparison — 2026
Retatrutide
Cagrilintide
Vendors Carrying Both
30 vendors stock both Retatrutide and Cagrilintide — convenient if you want to bundle an order.
Safety Notes
Retatrutide
FDA: Not FDA-approved (Phase III)
Phase II showed strong efficacy/tolerability; GI side effects; novel mechanism; promising safety data
Cagrilintide
FDA: Not FDA-approved (Phase III)
Phase III trials show good tolerability; GI side effects; injection site reactions
Explore Further
Retatrutide
Cagrilintide